Nottingham Group Wins $1.1M for Alzheimer's Protein Biomarker Research
August 12, 2011
Nottingham Group Wins $1.1M for Alzheimer's Protein Biomarker Research
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Initial Analysis of ADNI Plasma Proteome Data Suggests Possible Protein Signatures for Alzheimer's
December 10, 2010 / ProteoMonitor - Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor - Study Suggests Flaws in Standard Cognitive Alzheimer's Test Could Undermine Drug, Biomarker Research
December 21, 2012 / ProteoMonitor - Analysis of Alzheimer's Plasma Proteome Dataset Highlights Benefits of Longitudinal Data
April 6, 2012 / ProteoMonitor - Lund Study Highlights Difficulties Facing Alzheimer's Plasma Protein Biomarker Research
January 30, 2012 / ProteoMonitor